Wenqiang Yan

9PUBLICATIONS
41CO-AUTHORS
Cancer cell biologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Single-Cell Profiling Identifies SLC2A5-Mediated Fructose Metabolism as a Vulnerability in Primary CNS Lymphoma.

|Feb 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Wenqiang Yan, Chenxing Du, Rui Lv

|May 30, 2025
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.

Wenqiang Yan, Jiao Chang, Chenxing Du

|Nov 28, 2024
Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.

Wenqiang Yan, Yu Xiong, Rui Lv

|Jun 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Jian Cui, Xiaoyun Li, Shuhui Deng

|Jan 22, 2024
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.

Xuehan Mao, Wenqiang Yan, David Mery

Pageof 2

Frequent Collaborators

6 joint publications

Dehui Zou

6 joint publications

Gang An

6 joint publications

Chenxing Du

4 joint publications

Yan Xu